ArticleRenal failure2025
Initial serum chloride is associated with all-cause mortality in critically ill patients with acute kidney injury.
Article in Renal failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Dysregulated serum chloride and clinical outcomes in critically ill adults: A systematic review and meta-analysis.PloS one · 2025Pooled it
- Multiple electrolyte imbalances in hospitalized patients: a multimorbidity perspective from a large, retrospective cohort study.Annals of medicine · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveDisorders related to serum chloride concentration have recently attracted considerable interest. We sought to determine whether initial serum chloride was associated with an increased risk of all-cause mortality among critically ill patients diagnosed with acute kidney injury (AKI).
methodsWe searched the Multiparameter Intelligent Monitoring in the Intensive Care IV database to retrieve clinical data, including demographic factors, clinical variables, lab tests, and scoring systems. Hypothesis testing was conducted using a range of statistical approaches, including the generalized additive model, the Cox proportional hazards model, and subgroup analyses.
resultsOur research included 19,107 participants who met the set criteria. We found that the levels of chloride in the patient's serum upon admission had a similar inverted L-shaped relationship with the 30-day all-cause mortality rate in AKI. In multivariate analysis following the adjustment of confounders such as sex, ethnicity, and age, compared with the referent group (100-105 mmol/L), low-chloride (< 100 mmol/L) was a considerable risk predictor for 30-day, 90-day, and 365-day all-cause mortality. In particular, the HRs (95% CIs) for chloride were 1.49 (1.36, 1.63), 1.48 (1.36, 1.61), and 1.59 (1.47, 1.71). After adjusting additional clinical characteristics, low-chloride levels still served independently as a major predictor of all-cause mortality over 30 days, 90 days, and 365 days (HR, 95% CI: 1.24, 1.09-1.41; 1.17, 1.04-1.32; 1.27, 1.14-1.42).
conclusionsThe probability of all-cause mortality was higher in severely ill individuals with AKI who had lower baseline serum chloride levels upon admission to the intensive care unit (ICU).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.